Abstract:Background Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) is the most sensitive technique for evaluating gene expression levels. Choosing appropriate reference genes (RGs) is critical for normalizing and evaluating changes in the expression of target genes. However, uniform and reliable RGs for breast cancer research have not been identified, limiting the value of target gene expression studies. Here, we provide a novel approach for mining RGs by using the RNA-seq dataset to identify reliable and accurate RGs that can be applied to different types of breast cancer tissues and cell lines. Methods First, we compiled the transcriptome profiling data from the TCGA database involving 1217 samples to identify novel RGs and then ten genes (SF1, TARDBP, THRAP3, QRICH1, TRA2B, SRSF3, YY1, DNAJC8, RNF10, and RHOA) with relatively stable expression levels were chosen as novel candidate RGs. Additionally, six conventional RGs (ACTB, TUBA1A, RPL13A, B2M, GAPDH, and GUSB) were also selected. To determine and validate the optimal RGs we performed qRT-PCR experiments on 87 samples from 5 types of surgically excised breast tumor specimens including HR+HER2-, HR+HER2+, HR-HER2-, HR-HER2+, breast cancer after neoadjuvant chemotherapy (NAC) and their matched para-carcinoma tissues, furthermore, we also included a benign breast tumor sample. Six biological replicates were included for each tissue. Moreover, we assessed 7 breast cancer cell lines (MCF-10A, MCF-7, T-47D, MDA-MB-231, MDA-MB-468, as well as MDA-MB-231 with either CNR2 knockdown or overexpression; 3 biological replicates for each line). Five statistical algorithms (geNorm, NormFinder, ΔCt method, BestKeeper, and ComprFinder) were used to assess the stability of expression of each RG across all breast cancer tissues and cell lines. Results Our results show that RG combinations SF1+TRA2B+THRAP3 and THRAP3+RHOA+QRICH1 showed stable expression in breast cancer tissues and cell lines, respectively, and that these two combinations displayed good interchangeability. Therefore, we propose that the above two combinations are optimal triplet RGs for breast cancer research. Conclusions In summary, we identified novel and reliable RG combinations for breast cancer research based on a public RNA-seq dataset which lays a solid foundation for accurate normalization of qRT-PCR results across different breast cancer tissues and cells.

Selection of Internal References for Qrt-Pcr Assays of Human Hepatocellular Carcinoma Cell Lines

Evaluation of Potential Reference Genes for Qrt-Pcr Studies in Human Hepatoma Cell Lines Treated with TNF-α

Selection of Reference Genes for Real-Time PCR in Human Hepatocellular Carcinoma Tissues

Suitable Reference Genes for Real-Time PCR in Human HBV-related Hepatocellular Carcinoma with Different Clinical Prognoses

Selection of Suitable Reference Genes for Qpcr Gene Expression Analysis of HepG2 and L02 in Four Different Liver Cell Injured Models.

Evaluation and Validation of Suitable Reference Genes for Reverse Transcription-Quantitative Polymerase Chain Reaction Studies in Cholangiocarcinoma Patients and Cell Lines.

Selection of reference genes for RT-qPCR analysis in tumor tissues from male hepatocellular carcinoma patients with hepatitis B infection and cirrhosis.

Identification of suitable reference genes for gene expression studies of human serous ovarian cancer by real-time polymerase chain reaction.

Identification of Valid Reference Genes for the Normalization of RT-qPCR Expression Studies in Human Breast Cancer Cell Lines Treated with and without Transient Transfection

Screening and validation of the optimal panel of reference genes in colonic epithelium and relative cancer cell lines

Identification of suitable reference genes for gene expression studies using quantitative polymerase chain reaction in lung cancer in vitro.

Identification of Reference Genes for Qrt-Pcr in Human Lung Squamous-Cell Carcinoma by RNA-Seq.

Validation of Internal Reference Genes for Relative Quantitation Studies of Gene Expression in Human Laryngeal Cancer.

Identification of Suitable Reference Genes for Investigating Gene Expression in Human Gallbladder Carcinoma Using Reverse Transcription Quantitative Polymerase Chain Reaction

Selecting Optimal Reference Genes for Breast Cancer Research

Identification of Suitable Reference Genes for Measurement of Gene Expression in Human Cervical Tissues.

Identification of Suitable Candidate Reference Genes for Gene Expression Analysis by RT-qPCR in Peripheral Blood Mononuclear Cells of CHB Patients

Selection of Reference Genes for Gene Expression Studies in Human Bladder Cancer Using SYBR-Green Quantitative Polymerase Chain Reaction.

Validation of Reference Genes for the Normalization of RT-qPCR Expression Studies in Human Tongue Carcinoma Cell Lines and Tissue.

Tissue-specific Selection of Optimal Reference Genes for Expression Analysis of Anti-Cancer Drug-Related Genes in Tumor Samples Using Quantitative Real-Time RT-PCR.

Experimental assessment of robust reference genes for qRT-PCR in lung cancer studies